Brief: ESSA Pharma Reports Q4 Loss Per Share $0.20
Nov 18 (Reuters) - ESSA Pharma Inc EPIX.O :
* ESSA PHARMA PROVIDES CORPORATE UPDATE AND REPORTS
FINANCIAL
RESULTS FOR FISCAL FOURTH QUARTER AND YEAR ENDED SEPTEMBER 30,
2021
* Q4 LOSS PER SHARE $0.20
Further company coverage: EPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ESSA Pharma
See all newsBrief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: ESSA Pharma Provides Update On Its Application To The Supreme Court Of British Columbia For Amended Interim Order
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics